Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 5
Transcatheter embolization of bronchial arteries in the treatment of haemoptysis
Vinko Vidjak, Karlo Novačić, Andrija Hebrang, Ivica Mažuranić, Miroslav Samaržija, Spomenka Ljubić, Tomislav Breitenfeld, Branimir Klasić
Izvirni znanstveni članek
Oznake: krvavitev;hemoptiza;bronhialna arterija;zdravljenje;embolizacija;
Leto: 2009 Vir: dLib.si Digitalna knjižnica Slovenije
Emerging therapies and new directions in the treatment of pulmonary arterial hypertension
Grzegorz Kopec, Andris Skride, Egle Ereminiene, Iveta Šimkova, Roxana Enache, Miroslav Samaržija, Barbara Salobir, Pavel Jansa
Pregledni znanstveni članek
Oznake: activin signaling inhibitors;novel therapies;risk assessment;treatment strategy;sotatercept;
Pulmonary arterial hypertension (PAH) is a severe and progressive disease with limited survival prospects under currently available therapies. Since the 2022 edition of the European Society of Cardiology and European Respiratory Society guidelines on pulmonary hypertension, substantial clinical evid ...
Leto: 2025 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
Agnes Bilecz, Paul Stockhammer, Dirk Theegarten, Izidor Kern, Marko Jakopović, Miroslav Samaržija, Thomas Klikovits, Mir Alireza Hoda, Balazs Dome, Felicitas Oberndorfer
Izvirni znanstveni članek
Oznake: epiteloidni maligni plevralni mezoteliom;histološki podtipi;epithelioid malignant pleural mesothelioma;histological subtypes;
Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal prognosis. While the epithelioid type is associated with a more favourable outcome, additional factors are needed to further stratify prognosis and to identify patients who can benefit from multimodal treatment. As epithelioid M ...
Leto: 2020 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer
Lidija Ljubicic, Urška Janžič, Mojca Unk, Ana Sophie Terglav, Katja Mohorčič, Fran Seiwerth, Lela Bitar, Sonja Badovinac, Sanja Pleština, Marta Koršić, Suzana Kukulj, Miroslav Samaržija, Marko Jakopović
Izvirni znanstveni članek
Oznake: onkologija;pljučne bolezni;antiangiogena terapija;docetaksel;nintedanib;
Leto: 2023 Vir: Onkološki inštitut Ljubljana (OI)
High burden of clonal mast cell disorders and hereditary α-[alpha]tryptasemia in patients who need Hymenoptera venom immunotherapy
Peter Korošec, Gunter Sturm, Jonathan J. Lyons, Tinkara Pirc Marolt, Manca Svetina, Mitja Košnik, Mihaela Zidarn, Mark Kačar, Nina Frelih, Nika Lalek, Ajda Demšar, Samo Zver, Matevž Škerget, Ewa Czarnobilska, Wojciech Dyga, Sanja Popović-Grle, Miroslav Samaržija, Lisa Arzt-Gradwohl, Urban Čerpes, Grzegorz Porebski, Branko Pevec, Eva Schadelbauer, Peter Kopač, Julij Gyula Šelb, Matija Rijavec
Izvirni znanstveni članek
Oznake: anaphylaxis;hereditary α-tryptasemia;hypersensitivity;immunotherapy;mast cell;mastocytosis;venom;
Background In patients who require venom immunotherapy (VIT), there is a need to identify underlying mast cell (MC) disorders since these may affect the risk and severity of future sting reactions and the long-term effectiveness of VIT. Methods 1319 individuals with Hymenoptera venom allergy (H ...
Leto: 2024 Vir: Repozitorij Univerze v Ljubljani (RUL)
Št. zadetkov: 5
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: